1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Middle East and Africa Metastatic Cancer Drugs Market – By Cancer Type

1.3.2        Middle East and Africa Metastatic Cancer Drugs Market – By Route of Administration

1.3.3        Middle East and Africa Metastatic Cancer Drugs Market – By Drug Class

1.3.4        Middle East and Africa Metastatic Cancer Drugs Market – By Product

1.3.5        Middle East and Africa Metastatic Cancer Drugs Market – By End User

1.3.6        Middle East and Africa Metastatic Cancer Drugs Market – By Country

2.           Middle East and Africa Metastatic Cancer Drugs Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Middle East and Africa Metastatic Cancer Drugs Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Middle East and Africa– PEST Analysis

4.3         Expert Opinion

5.           Middle East and Africa Metastatic Cancer Drugs Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        High Prevalence of Metastatic Cancer

5.1.2        Government Initiatives to Support Developments in Cancer Treatment

5.2         Market Restraints

5.2.1        High Cost of Oncology Drugs

5.3         Market Opportunities

5.3.1        Investments in Artificial Intelligence for Oncology Drug Development

5.4         Future Trends

5.4.1        Increase in Launch of Metastatic Cancer Drugs

5.5         Impact analysis

6.           Middle East and Africa Metastatic Cancer Drugs Market –Country Analysis

6.1         Middle East and Africa Metastatic Cancer Drugs Market Revenue Forecast and Analysis

6.1.1        Middle East and Africa : Middle East and Africa Metastatic Cancer Drug Market - Revenue and Forecasts to 2028, (US$ Mn)

7.           Middle East and Africa Metastatic Cancer Drug Market Analysis – By Cancer Type

7.1         Overview

7.2         Middle East and Africa Metastatic Cancer Drug Market Revenue Share, by Cancer Type (2021 and 2028)

7.2.1        Middle East & Africa Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

7.3         Breast Cancer

7.3.1        Overview

7.3.2        Breast Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Lung Cancer

7.4.1        Overview

7.4.2        Lung Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Liver Cancer

7.5.1        Overview

7.5.2        Liver Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

7.6         Hematological Cancer

7.6.1        Overview

7.6.2        Haematological Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

7.7         Brain Cancer

7.7.1        Overview

7.7.2        Brain Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

7.8         Prostate Cancer

7.8.1        Overview

7.8.2        Prostate Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

7.9         Pancreatic Cancer

7.9.1        Overview

7.9.2        Pancreatic Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

7.10      Others

7.10.1     Overview

7.10.2     Others: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

8.           Middle East and Africa Metastatic Cancer Drug Market – By Route of Administration

8.1         Overview

8.2         Middle East and Africa Metastatic Cancer Drug Market, by Route of Administration, 2021 and 2028 (%)

8.2.1        Middle East & Africa Metastatic Cancer Drug Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

8.3         Intravenous

8.3.1        Overview

8.3.2        Intravenous: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Intramuscular

8.4.1        Overview

8.4.2        Intramuscular: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Oral

8.5.1        Overview

8.5.2        Oral: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Others

8.6.1        Overview

8.6.2        Others: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

9.           Middle East and Africa Metastatic Cancer Drug Market – By Drug Class

9.1         Overview

9.2         Middle East and Africa Metastatic Cancer Drug Market, by Drug Class, 2021 and 2028 (%)

9.2.1        Middle East & Africa Metastatic Cancer Drug Market, by Drug Class– Revenue and Forecast to 2028 (USD Million)

9.3         HER2 Inhibitors

9.3.1        Overview

9.3.2        HER2 Inhibitors: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Immune Checkpoints Inhibitors

9.4.1        Overview

9.4.2        Immune Checkpoints Inhibitors: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

9.5         PARP Inhibitors

9.5.1        Overview

9.5.2        PARP Inhibitors: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

9.6         Kinase Inhibitors

9.6.1        Overview

9.6.2        Kinase Inhibitors: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

9.7         Others

9.7.1        Overview

9.7.2        Others: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

10.        Middle East and Africa Metastatic Cancer Drug Market – By Product

10.1      Overview

10.2      Middle East and Africa Metastatic Cancer Drug Market, by Product, 2021 and 2028 (%)

10.2.1     Middle East & Africa Metastatic Cancer Drug Market, by Product– Revenue and Forecast to 2028 (USD Million)

10.3      Branded

10.3.1     Overview

10.3.2     Branded: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

10.4      Generics and Biosimilars

10.4.1     Overview

10.4.2     Generics and Biosimilars: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

11.        Middle East and Africa Metastatic Cancer Drug Market – By End User

11.1      Overview

11.2      Middle East and Africa Metastatic Cancer Drug Market, by End User, 2021 and 2028 (%)

11.2.1     Middle East & Africa: Metastatic Cancer Drug Market, by End User, 2019–2028 (USD Million)

11.3      Hospital

11.3.1     Overview

11.3.2     Hospitals: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

11.4      Specialty Clinic

11.4.1     Overview

11.4.2     Specialty Clinics: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

11.5      Others

11.5.1     Overview

11.5.2     Others: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

12.        Middle East and Africa Metastatic Cancer Drugs Market – Regional Analysis

12.1      Middle East and Africa: Metastatic Cancer Drugs Market

12.1.1     Overview

12.1.2     Middle East & Africa: Metastatic Cancer Drug Market, by Country, 2021 & 2028 (%)

12.1.2.1       Saudi Arabia: Metastatic Cancer Drug Market - Revenue and Forecast to 2028 (USD Million)

12.1.2.1.1       Saudi Arabia: Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.1.2       Saudi Arabia Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

12.1.2.1.3       Saudi Arabia Metastatic Cancer Drug Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

12.1.2.1.4       Saudi Arabia Metastatic Cancer Drug Market, by Drug Class– Revenue and Forecast to 2028 (USD Million)

12.1.2.1.5       Saudi Arabia Metastatic Cancer Drug Market, by Product– Revenue and Forecast to 2028 (USD Million)

12.1.2.1.6       Saudi Arabia: Metastatic Cancer Drug Market, by End User, 2019–2028 (USD Million)

12.1.2.2       UAE: Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.2.1       UAE: Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.2.2       UAE Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

12.1.2.2.3       UAE Metastatic Cancer Drug Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

12.1.2.2.4       UAE Metastatic Cancer Drug Market, by Drug Class– Revenue and Forecast to 2028 (USD Million)

12.1.2.2.5       UAE Metastatic Cancer Drug Market, by Product– Revenue and Forecast to 2028 (USD Million)

12.1.2.2.6       UAE: Metastatic Cancer Drug Market, by End User, 2019–2028 (USD Million)

12.1.2.3       South Africa: Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.3.1       South Africa: Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.3.2       South Africa Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

12.1.2.3.3       South Africa Metastatic Cancer Drug Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

12.1.2.3.4       South Africa Metastatic Cancer Drug Market, by Drug Class– Revenue and Forecast to 2028 (USD Million)

12.1.2.3.5       South Africa Metastatic Cancer Drug Market, by Product– Revenue and Forecast to 2028 (USD Million)

12.1.2.3.6       South Africa: Metastatic Cancer Drug Market, by End User, 2019–2028 (USD Million)

12.1.2.4       Rest of Middle East and Africa: Metastatic Cancer Drug Market - Revenue and Forecast to 2028 (USD Million)

12.1.2.4.1       Rest of Middle East and Africa: Metastatic Cancer Drug Market - Revenue and Forecast to 2028 (USD Million)

12.1.2.4.2       Rest of Middle East & Africa Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

12.1.2.4.3       Rest of Middle East & Africa Metastatic Cancer Drug Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

12.1.2.4.4       Rest of Middle East & Africa Metastatic Cancer Drug Market, by Drug Class– Revenue and Forecast to 2028 (USD Million)

12.1.2.4.5       Rest of Middle East & Africa Metastatic Cancer Drug Market, by Product– Revenue and Forecast to 2028 (USD Million)

12.1.2.4.6       Rest of Middle East & Africa: Metastatic Cancer Drug Market, by End User, 2019–2028 (USD Million)

13.        Middle East and Africa Metastatic Cancer Drug Market –Industry Landscape

13.1      Overview

13.2      Growth Strategies in the Middle East and Africa Metastatic Cancer Drug Market, 2021-2028

13.3      Inorganic Developments

13.3.1     Overview

13.4      Organic Growth Strategies

13.4.1     Overview

14.        Company Profiles

14.1      AbbVie Inc.

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      Amgen Inc.

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      Bristol-Myers Squibb Company

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4      F. HOFFMANN-LA ROCHE LTD.

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      Novartis AG

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6      Astrazeneca

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

14.7      MERCK KGaA

14.7.1     Key Facts

14.7.2     Business Description

14.7.3     Products and Services

14.7.4     Financial Overview

14.7.5     SWOT Analysis

14.7.6     Key Developments

14.8      Pfizer Inc. (Arena Pharmaceutical GmbH)

14.8.1     Key Facts

14.8.2     Business Description

14.8.3     Products and Services

14.8.4     Financial Overview

14.8.5     SWOT Analysis

14.8.6     Key Developments

14.9      Johnson and Johnson Services, Inc.

14.9.1     Key Facts

14.9.2     Business Description

14.9.3     Products and Services

14.9.4     Financial Overview

14.9.5     SWOT Analysis

14.9.6     Key Developments

15.        Appendix

15.1      About The Insight Partners

15.2      Glossary of Terms

LIST OF TABLES

Table 1.             Middle East and Africa: Middle East and Africa Metastatic Cancer Drug Market - Revenue and Forecasts to 2028, (US$ Mn).

Table 2.             Middle East & Africa Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

Table 3.             Middle East & Africa Metastatic Cancer Drug Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 4.             Middle East & Africa Metastatic Cancer Drug Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 5.             Middle East & Africa Metastatic Cancer Drug Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 6.             Middle East & Africa Metastatic Cancer Drug Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 7.             Saudi Arabia Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

Table 8.             Saudi Arabia Metastatic Cancer Drug Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 9.             Saudi Arabia Metastatic Cancer Drug Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 10.          Saudi Arabia Metastatic Cancer Drug Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 11.          Saudi Arabia Metastatic Cancer Drug Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 12.          UAE Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

Table 13.          UAE Metastatic Cancer Drug Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 14.          UAE Metastatic Cancer Drug Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 15.          UAE Metastatic Cancer Drug Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 16.          UAE Metastatic Cancer Drug Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 17.          South Africa Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

Table 18.          South Africa Metastatic Cancer Drug Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 19.          South Africa Metastatic Cancer Drug Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 20.          South Africa Metastatic Cancer Drug Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 21.          South Africa Metastatic Cancer Drug Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 22.          Rest of Middle East & Africa Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

Table 23.          Rest of Middle East & Africa Metastatic Cancer Drug Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 24.          Rest of Middle East & Africa Metastatic Cancer Drug Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 25.          Rest of Middle East & Africa Metastatic Cancer Drug Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 26.          Rest of Middle East & Africa Metastatic Cancer Drug Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 27.          Recent Inorganic Growth Strategies in the Middle East and Africa Metastatic Cancer Drug Market

Table 28.          Recent Organic Growth Strategies in the Middle East and Africa Metastatic Cancer Drug Market

Table 29.          Glossary of Terms, Middle East and Africa Metastatic Cancer Drugs Market

LIST OF FIGURES

Figure 1.           Middle East and Africa Metastatic Cancer Drugs Market Segmentation

Figure 2.           Middle East and Africa Metastatic Cancer Drugs Market Overview

Figure 3.           The PARP Inhibitors Segment Held The Largest Share of Drug Class Segment in Middle East and Africa Metastatic Cancer Drugs Market

Figure 4.           Germany Region Is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           Middle East and Africa PEST Analysis

Figure 6.           Expert Opinion

Figure 7.           Middle East and Africa Metastatic Cancer Drugs Market Impact Analysis of Driver and Restraints

Figure 8.           Middle East and Africa Metastatic Cancer Drugs Market – Revenue Forecast and Analysis – 2021- 2028

Figure 9.           Middle East and Africa Metastatic Cancer Drug Market Revenue Share, by Cancer Type (2021 and 2028)

Figure 10.        Breast Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        Lung Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Liver Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Hematological Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Brain Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Prostate Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Pancreatic Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Others: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Middle East and Africa Metastatic Cancer Drug Market, by Route of Administration, 2021 and 2028 (%)

Figure 19.        Intravenous: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Intramuscular: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Oral: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Others: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Middle East and Africa Metastatic Cancer Drug Market, by Drug Class, 2021 and 2028 (%)

Figure 24.        HER2 Inhibitors: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Immune Checkpoints Inhibitors: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        PARP Inhibitors: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Kinase Inhibitors: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Others: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Middle East and Africa Metastatic Cancer Drug Market, by Product, 2021 and 2028 (%)

Figure 30.        Branded: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Generics and Biosimilars: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Middle East and Africa Metastatic Cancer Drug Market, by End User, 2021 and 2028 (%)

Figure 33.        Hospitals: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Specialty Clinics: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35.        Others: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36.        Middle East and Africa: Metastatic Cancer Drugs Market, by Key Country – Revenue (2021) (US$ ‘Million)

Figure 37.        Middle East & Africa: Metastatic Cancer Drug Market, by Country, 2021 & 2028 (%)

Figure 38.        Saudi Arabia: Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)

Figure 39.        UAE: Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)

Figure 40.        South Africa: Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)

Figure 41.        Rest of Middle East and Africa: Metastatic Cancer Drug Market - Revenue and Forecast to 2028 (USD Million)

Figure 42.        Growth Strategies in the Middle East and Africa Metastatic Cancer Drug Market, 2021-2028